Skip to main content

Non-coronary Interventions in the Elderly

  • Chapter
Interventional Cardiology in the Elderly
  • 569 Accesses

Abstract

Non-coronary cardiac interventions increasingly emerge as treatment options for structural heart disease in patients with high or prohibitive surgical risk that is mainly encountered in the elderly population. Transcatheter repair for aortic stenosis and mitral regurgitation the most common valvular diseases of old age are well established. Interventional occlusion of atrial septal defects and other congenital or acquired shunts has also been shown to be a feasible, safe and beneficial option for the elderly. In addition transcatheter occlusion of left atrial appendage arises as replacement for anticoagulation in atrial fibrillation patients at increased embolic risk with contraindications against anticoagulation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Jung B, Baron G, Butchart EG, Delahaye F, Gohlke-Bärwolf C, Levang OW, Tornos P, Vanoverschelde JL, Vermeer F, Boersma E, Ravaud P, Vahanian A. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on valvular heart disease. Eur Heart J. 2003;24:1231–43.

    Article  Google Scholar 

  2. Jang SY, Ju EY, Seo SR, Choi JY, Park SJ, Kim DK, Park SW. Changes in the etiology of valvular heart disease in the rapidly aging Korean population. Int J Cardiol. 2014;174:355–9.

    Article  PubMed  Google Scholar 

  3. Carabello RA, Paulus WJ. Aortic stenosis. Lancet. 2009;373:956–66.

    Article  PubMed  Google Scholar 

  4. Nashef SA, Roques F, Sharples LD, Nilsson J, Smith C, Goldstone AR, Lockowandt U. EuroSCORE II. Eur J Cardiothorac Surg. 2012;41:734–44.

    Article  PubMed  Google Scholar 

  5. Wendt D, Osswald BR, Kayser K, Thielmann M, Tossios P, Massoudy P, Karnler M, Jacob H. Society of Thoracic Surgeons score is superior to the EuroSCORE determining mortality in high risk patients undergoing isolated aortic valve replacement. Ann Thorac Surg. 2009;88:468–78.

    Article  PubMed  Google Scholar 

  6. Mirabel M, Jung B, Baron G, Messika-Zeitoun D, Détain D, Vanoverschelde JL, Butchart EG, Ravaud P, Vahanian A. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart J. 2007;28:1358–65.

    Article  PubMed  Google Scholar 

  7. Long T, Lopez BM, Berberian C, Cunningham MJ, Starnes VA, Cohen RG. Exercise hemodynamics and quality of life after aortic valve replacement for aortic stenosis in the elderly using the Hancock II bioprosthesis. Cardiol Res Pract. 2014;2014:151282. doi:10.1155/2014/151282. Epub 2014 Dec 2.

  8. Bekelman DB, Rumsfeld JS, Havranek EP, Yamashita TE, Hutt E, Gottlieb SH, Kutner JS. Symptom burden, depression, and spiritual well-being: a comparison of heart failure and advanced cancer patients. J Gen Intern Med. 2009;24:592–8.

    Article  PubMed Central  PubMed  Google Scholar 

  9. Lieberman EB, Bashore TM, Hermiller JB, Wilson JS, Pieper KS, Keeler GP, Pierce CH, Kisslo KB, Harrison JK, Davidson CJ. Balloon aortic valvuloplasty in adults: failure of procedure to improve long-term survival. J Am Coll Cardiol. 1995;26:1522–8.

    Article  CAS  PubMed  Google Scholar 

  10. Safian RD, Berman AD, Diver DJ, McKay LL, Come PC, Riley MF, Warren SE, Cunningham MJ, Wyman RM, Weinstein JS. Balloon aortic valvuloplasty in 170 consecutive patients. N Engl J Med. 1988;19:125–30.

    Article  Google Scholar 

  11. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S, PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597–607.

    Article  CAS  PubMed  Google Scholar 

  12. Beigel R, Wunderlich NC, Kar S, Siegel RJ. The evolution of percutaneous mitral valve repair therapy: lessons learned and implications for patient selection. J Am Coll Cardiol. 2014;64:2688–700.

    Article  PubMed  Google Scholar 

  13. Nishimura RA, Otto CM, Bonow RO, Carabello BA, 3rd Erwin JP, Guyton RA, O’Gara PT, Ruiz CE, Skubas NJ, Sorajja P, 3rd Sundt TM, Thomas JD, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Creager MA, Curtis LH, DeMets D, Guyton RA, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Stevenson WG, Yancy CW, American College of Cardiology; American College of Cardiology/American Heart Association; American Heart Association. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg. 2014;148:e1–132.

    Article  PubMed  Google Scholar 

  14. Block PC, Burstein S, Casale PN, Kramer PH, Teirstein P, Williams DO, Reisman M. Percutaneous left atrial appendage occlusion for patients in atrial fibrillation suboptimal for warfarin therapy: 5-year results of the PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) Study. JACC Cardiovasc Interv. 2009;2:594–600.

    Article  PubMed  Google Scholar 

  15. Reddy VY, Holmes D, Doshi SK, Neuzil P, Kar S. Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry. Circulation. 2011;123:417–24.

    Article  PubMed  Google Scholar 

  16. Genders TS, Steyerberg EW, Hunink MG, Nieman K, Galema TW, Mollet NR, de Feyter PJ, Krestin GP, Alkadhi H, Leschka S, Desbiolles L, Meijs MF, Cramer MJ, Knuuti J, Kajander S, Bogaert J, Goetschalckx K, Cademartiri F, Maffei E, Martini C, Seitun S, Aldrovandi A, Wildermuth S, Stinn B, Fornaro J, Feuchtner G, De Zordo T, Auer T, Plank F, Friedrich G, Pugliese F, Petersen SE, Davies LC, Schoepf UJ, Rowe GW, van Mieghem CA, van Driessche L, Sinitsyn V, Gopalan D, Nikolaou K, Bamberg F, Cury RC, Battle J, Maurovich-Horvat P, Bartykowszki A, Merkely B, Becker D, Hadamitzky M, Hausleiter J, Dewey M, Zimmermann E, Laule M. Prediction model to estimate presence of coronary artery disease: retrospective pooled analysis of existing cohorts. BMJ. 2012;344, e3485.

    Article  PubMed Central  PubMed  Google Scholar 

  17. Brunner KJ, Bunch TJ, Mullin CM, May HAT, Bair TL, Elliot DW, Anderson JL, Mahapatra S. Clinical predictors of risk for atrial fibrillation: implications for diagnosis and monitoring. Mayo Clin Proc. 2014;89:1498–505.

    Article  PubMed  Google Scholar 

  18. Lip GY, Frison L, Halperin JL, Dane DA. Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) score. J Am Coll Cardiol. 2011;57:173–80.

    Article  CAS  PubMed  Google Scholar 

  19. Varadarajan P, Kapoor N, Bansal RC, Pai RG. Clinical profile and natural history of 453 nonsurgically managed patients with severe aortic stenosis. Ann Thorac Surg. 2006;82:2111–5.

    Article  PubMed  Google Scholar 

  20. Bach DS, Siao D, Girard SE, Duvernoy C, McCallister Jr BD, Gualano SK. Evaluation of patients with severe symptomatic aortic stenosis who do not undergo aortic valve replacement: the potential role of subjectively overestimated operative risk. Circ Cardiovasc Qual Outcomes. 2009;2:533–9.

    Article  PubMed  Google Scholar 

  21. Ross Jr J, Braunwald E. The influence of corrective operations on the natural history of aortic stenosis. Circulation. 1968;38(1 Suppl):61–7.

    PubMed  Google Scholar 

  22. Frank S, Johnson A, Ross Jr J. Natural history of valvular aortic stenosis. Br Heart J. 1973;35:41–6.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  23. Cribier A, Savin T, Saoudi N, Rocha P, Berland J, Lelac B. Percutaneous transluminal valvuloplasty of acquired aortic stenosis in elderly patients: an alternative to valve replacement? Lancet. 1986;1:63–7.

    Article  CAS  PubMed  Google Scholar 

  24. National Heart Lung and Blood Institute participants group. Percutaneous balloon aortic valvuloplasty. Acute and 30-day follow-up results in 674 patients from the NHLBI Balloon Valvuloplasty Registry. Circulation. 1991;84:2383–97.

    Google Scholar 

  25. Davies H. Catheter mounted valve for temporary relief of aortic insufficiency. Lancet. 1965;1:926–9.

    Article  CAS  PubMed  Google Scholar 

  26. Bonhoeffer P, Boudjemline Y, Saliba Z, Merckx J, Aggoun Y, Bonnet D, Acar P, Le Bidois J, Sidi D, Kachaner J. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet. 2000;356:1403–5.

    Article  CAS  PubMed  Google Scholar 

  27. Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, Derumeaux G, Anselme F, Laborde F, Leon MB. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002;10:3006–8.

    Article  Google Scholar 

  28. Cribier A, Eltchaninoff H, Tron C, Bauer F, Agatiello C, Sebagh L, Bash A, Nusimovici D, Litzler PY, Bessou JP, Leon MB. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol. 2004;43:698–703.

    Article  PubMed  Google Scholar 

  29. Hamm CW, Möllmann H, Holzhey D, Beckmann A, Veit C, Figulla HR, Cremer J, Kuck KH, Lange R, Zahn R, Sack S, Schuler G, Walther T, Beyersdorf F, Böhm M, Heusch G, Funkat AK, Neumann T, Papoutsis K, Schneider S, Welz A, Mohr FW, GARY-Executive Board. The German Aortic Valve Registry (GARY): in-hospital outcome. Eur Heart J. 2014;35:1588–98.

    Article  PubMed Central  PubMed  Google Scholar 

  30. Holinski S, Jessen S, Neumann K, Konnertz W. Predictive Power and Implication of EuroSCORE, EuroSCORE II and STS Score for Isolated Repeated Aortic Valve Replacement. Ann Thorac Cardiovasc Surg. 2015;21:242–6.

    Article  PubMed  Google Scholar 

  31. Green P, Woglom AE, Genereux P, Daneault P, Paradis JM, Schnell S, Hawkey M, Maurer MS, Kirtane AJ, Kodali S, Moses JW, Leon MB, Smith CR, Williams M. The impact of frailty status on survival after transcatheter aortic valve replacement in older adults with severe aortic stenosis: a single-center experience. JACC Cardiovasc Interv. 2012;5:974–81.

    Article  PubMed Central  PubMed  Google Scholar 

  32. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ, Anderson WN, Wang D, Pocock SJ, PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187–98.

    Article  CAS  PubMed  Google Scholar 

  33. Popma JJ, Adams DH, Reardon MJ, Yakubov SJ, Kleiman NS, Heimansohn D, Hermiller Jr J, Hughes GC, Harrison JK, Corselli J, Diez J, Kafi A, Schreiber T, Gleason TG, Conte J, Buchbinder M, Deeb GM, Carabello B, Serruys PW, Chenoweth S, Oh JK, CoreValve United States Investigators. Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. J Am Coll Cardiol. 2014;63:1972–81.

    Article  PubMed  Google Scholar 

  34. Adams DH, Popma JJ, Reardon MJ, Yakubov SJ, Coselli JS, Deeb GM, Gleason TG, Buchbinder M, Hermiller Jr J, Kleiman NS, Chetcuti S, Heiser J, Merhi W, Zorn G, Tadros P, Robinson M, Petrossian G, Hughes GC, Harrison JK, Conte J, Maini B, Mumtaz M, Chenoweth S, Oh JK, U.S. CoreValve Clinical Investigators. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014;370:1790–8.

    Article  CAS  PubMed  Google Scholar 

  35. Abdel-Wahab M, Mehilli J, Frerker C, Neumann FJ, Kurz T, Tölg R, Zachow D, Guerra E, Massberg S, Schäfer U, El-Mawardy M, Richardt G, CHOICE investigators. Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial. JAMA. 2014;311:1503–14.

    Article  CAS  PubMed  Google Scholar 

  36. Genereux P, Head SJ, Hahn R, Daneault B, Kodali S, Williams MR, van Mieghem NM, Alu MC, Serruys PW, Kappetein AP, Leon MB. Paravalvular leak after transcatheter aortic valve replacement: the new Achilles’ heel? A comprehensive review of the literature. J Am Coll Cardiol. 2013;61:1125–36.

    Article  PubMed  Google Scholar 

  37. Meredith IT, Walters DL, Dumonteil N, Worthley SG, Tchetche D, Manoharan G, Blackman DJ, Rioufol G, Hildick-Smith D, Whitbourn RJ, Lefevre T, Lange R, Müller R, Redwood S, Alloco DJ, Dawkins KD. Transcatheter aortic valve replacement for severe symptomatic aortic stenosis using a repositionable valve system: 30-day primary endpoint results from the REPRISE II study. J Am Coll Cardiol. 2014;64:1339–48.

    Article  Google Scholar 

  38. Webb J, Gerosa G, Lefevre T, Leipsic J, Spence M, Thomas M, Thielmann M, Treede H, Wendler O, Walther T. Multicenter evaluation of a next-generation balloon-expandable transcatheter aortic valve. J Am Coll Cardiol. 2014;64:2235–43.

    Article  PubMed  Google Scholar 

  39. Maisano F, Schreuder JJ, Oppizzi M, Florani B, Fino C, Alfieri O. The double-orifice technique as a standardized approach to treat mitral regurgitation due to sever myxomatous disease: surgical technique. Eur J Cardiothorac Surg. 2000;17:201–5.

    Article  CAS  PubMed  Google Scholar 

  40. Feldman T, Kar S, Rinaldi M, Fail P, Hermiller J, Smalling R, Whitlow PL, Gray W, Low R, Herrman HC, Lim S, Foster E, Glower D, EVEREST Investigators. Percutaneous mitral repair with the MitraClip system: safety and midtern durability in the initial EVEREST (Endovascular Valve Edge-to-Edge Repair Study) cohort. J Am Coll Cardiol. 2009;54:686–94.

    Article  PubMed  Google Scholar 

  41. Feldman T, Foster E, Glower DD, Kar S, Rinaldi MJ, Fail PS, Smalling RW, Siegel R, Rose GA, Engeron G, Loghin C, Trento A, Skipper ER, Fudge T, Letsou GV, Massaro JM, Mauri L, EVEREST II Investigators. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med. 2011;364:1395–406.

    Article  CAS  PubMed  Google Scholar 

  42. Mauri L, Foster E, Glower DD, Apruzzesse P, Massaro JM, Herrmann HC, Hermiller J, Gray W, Wang A, Pedersen WR, Bajwa T, Lasala J, Low R, Grayburn P, Feldman T, Everest II Investigators. 4-year results of a randomized controlled trial of percutaneous repair versus surgery for mitral regurgitation. J Am Coll Cardiol. 2013;62:317–28.

    Article  PubMed  Google Scholar 

  43. Whitlow PL, Feldman T, Pedersen WR, Lim DS, Kipperman R, Smalling R, Bajwa T, Herrmann HC, Lasala J, Maddux JT, Tuczu M, Kapadia S, Trento A, Siegel RJ, Foster E, Glower D, Mauri L, Kar S, Everest II Investigators. Acute and 12-month results with catheter-based mitral valve leaflet repair: the EVEREST II (Endovascular Valve Edge-to-Edge Repair) High Risk Study. J Am Coll Cardiol. 2012;59:130–9.

    Article  PubMed  Google Scholar 

  44. Maisano F, Franzen O, Baldus S, Schäfer U, Hausleiter J, Butter C, Ussia GP, Sievert H, Richardt G, Widder JD, Moccetti T, Schillinger W. Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe. J Am Coll Cardiol. 2013;17:1052–61.

    Article  Google Scholar 

  45. Baumgärtner H, Bonhoeffer P, de Groot NMS, de Haan F, Deanfield JE, Galie N, Gatzoulis MA, Gohlke-Baerwolf C, Kaemmerer H, Kilner P, Meijboom F, Mulder BJM, Oechslin E, Oliver JM, Serraf A, Szatmari A, Thaulow E, Vouhe PR, Walma E. ESC Guidelines for the management of grown-up congenital heart disease. Eur Heart J. 2010;31:2915–57.

    Article  PubMed  Google Scholar 

  46. Attie F, Rosas M, Granados N, Zabal C, Buendia A, Calderon J. Surgical treatment for secundum atrial septal defects in patients > 40 years old. J Am Coll Cardiol. 2001;38:2035–42.

    Article  CAS  PubMed  Google Scholar 

  47. Du ZD, Hijazi ZM, Kleinmann CS, Silvermann NH, Larntz K. Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: results of a multicenter nonrandomized trial. J Am Coll Cardiol. 2002;39:1836–44.

    Article  PubMed  Google Scholar 

  48. Butera G, Carminati M, Chessa M, Youssef R, Drago M, Giamberti A, Pome G, Bossone E, Frigola A. Percutaneous versus surgical closure of secundum atrial septal defect: comparison of early results and complications. Am Heart J. 2006;151:228–34.

    Article  PubMed  Google Scholar 

  49. Humenberger M, Rosenhek R, Gabriel H, Radar F, Heger M, Klaar U, Binder T, Probst P, Heinze G, Maurer G, Baumgartner H. Benefit of atrial septal defect closure in adults: impact of age. Eur Heart J. 2010;32:553–60.

    Article  PubMed Central  PubMed  Google Scholar 

  50. Al-Hindi A, Cao QL, Hijazi ZM. Transcatheter closure of atrial septal defect in the elderly. J Invasive Cardiol. 2009;21:70–5.

    PubMed  Google Scholar 

  51. Blackshear J, Odell J. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg. 1996;61:755–9.

    Article  CAS  PubMed  Google Scholar 

  52. Kanderian AS, Gillinov AM, Petterson GB, Blackstone E, Klein AL. Success of surgical left atrial appendage closure: assessment by transesophageal echocardiography. J Am Coll Cardiol. 2008;52:924–9.

    Article  PubMed  Google Scholar 

  53. Friedman PA, Asirvatham S, Dalegrave C, Kinoshita M, Danielsen AJ, Johnson SB, Hodge DO, Munger TM, Packer DL, Bruce CJ. Percutaneous epicardial left atrial appendage closure: preliminary results of an electrogram guided approach. J Cardiovasc Electrophysiol. 2009;20:908–15.

    Article  PubMed  Google Scholar 

  54. Sievert H, Lesh M, Trepels T, Omran H, Bartorelli A, Della Bella P, Nakai T, Reisman M, DiMario C, Block P, Kramer P, Fleschenberg D, Krumsdorf U, Scherer D. Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: early clinical experience. Circulation. 2002;105:1887–9.

    Article  PubMed  Google Scholar 

  55. Meier B, Palacios I, Windecker S, Rotter M, Cao QL, Keane D, Ruiz CE, Hijazi ZM. Transcatheter left atrial appendage occlusion with Amplatzer devices to obviate anticoagulation in patients with atrial fibrillation. Catheter Cardiovasc Interv. 2003;60:417–22.

    Article  PubMed  Google Scholar 

  56. Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, Mullin CM, Sick P, PROTECT AF Investigators. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet. 2009;374:534–42.

    Article  CAS  PubMed  Google Scholar 

  57. Reddy VY, Sievert H, Halperin J, Doshi SK, Buchbinder M, Neuzil P, Huber K, Whisenant B, Kar S, Swarup V, Gordon N, Holmes D, PROTECT AF Steering Committee and Investigators. Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial. JAMA. 2014;312:1988–98.

    Article  PubMed  Google Scholar 

  58. Holmes Jr DR, Kar S, Price MJ, Whisenant B, Sievert H, Doshi SK, Huber K, Reddy VY. Prospective randomized evaluation of the Watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol. 2014;64:1–12.

    Article  PubMed  Google Scholar 

  59. Meier B, Blaauw Y, Khattab AA, Lewalter T, Sievert H, Tondo C, Glikson M, Document Reviewers. EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion. Europace. 2014;16:1397–416.

    Article  PubMed  Google Scholar 

  60. Reddy VY, Möbius-Winkler S, Miller MA, Neuzil P, Schuler G, Wiebe J, Sick P, Sievert H. Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology). J Am Coll Cardiol. 2013;61:2551–6.

    Article  PubMed  Google Scholar 

  61. Park JW, Bethencourt A, Sievert H, Santoro G, Meier B, Walsh K, Lopez-Minguez JR, Meerkin D, Valdes M, Omerod O, Leithäuser B. Left atrial appendage closure with Amplatzer cardiac plug in atrial fibrillation: Initial European experience. Catheter Cardiovasc Interv. 2011;77:700–6.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ralf Birkemeyer MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Birkemeyer, R. (2015). Non-coronary Interventions in the Elderly. In: Rittger, H. (eds) Interventional Cardiology in the Elderly. Springer, Cham. https://doi.org/10.1007/978-3-319-21142-8_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-21142-8_8

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-21141-1

  • Online ISBN: 978-3-319-21142-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics